Feverfew Flowering Tops (Tanacetum parthenium)

Nomenclature & Taxonomic Classification

• Botanical Binomial: Tanacetum parthenium (L.) Sch.Bip. (Syn: Chrysanthemum parthenium)
• Family: Asteraceae
• Common Name(s): Feverfew, Featherfew, Midsummer Daisy, Bachelor’s Buttons
• Parts Used: Dried flowering tops and leaves.

Botanical Description, Habitat & Sustainability

• Physical Description: * Growth Habit: Hardy, aromatic perennial herbaceous plant growing 30–60 cm tall.
  • Morphology: Erect, branched, grooved, slightly hairy stems. Leaves are alternate, yellowish-green, deeply pinnatifid or bipinnate with fine hairs, emitting a powerful, bitter, pungent aroma when bruised. Produces dense terminal clusters of small daisy-like flower heads ($1.5–2\text{ cm}$ wide) with a flat yellow disk and short white ray florets.
• Habitat & Cultivation: Native to Southeastern Europe (the Balkan Peninsula); cultivated and naturalized globally across temperate regions. Thrives in full sun, well-drained waste soils, old gardens, and rocky borders.
• Sustainability Status: Highly secure and abundant wild weed; easily cultivated.

Energetics & Traditional Actions

• Western Tissue States: Corrects Constriction/Tension (relaxes persistent cerebral vascular tension) and Irritation (cools sharp neuralgic and inflammatory heat).
• Traditional Vector:
  • Ayurveda: Rasa (Taste): Tikta (Bitter), Katu (Pungent) | Virya (Energy): Sheeta (Cooling) | Vipaka (Post-Digestive Effect): Katu (Pungent) | Dosha Modulation: Decreases Pitta and Kapha; can elevate dry Vata if overused alone.
  • Traditional Chinese Medicine: Temperature: Cold | Taste: Bitter, Acrid | Organ Meridians Entered: Liver, Gallbladder, Pericardium
• Historical Folk Use: Historically termed “Featherfew” or “Fever-fugue” (driver away of fevers). Used in English herbalism since antiquity for severe headaches, hysterical nervous conditions, painful menstrual obstructions, and as a localized wash for insect stings.

Phytochemistry & Pharmacological Dynamics

• Primary Phytochemicals: Sesquiterpene lactones (primarily parthenolide up to 0.2–1% of leaf weight); volatile oils (camphor, chrysanthemyl acetate); flavonoids (apigenin, luteolin); melatonin.
• Mechanism of Action: > Feverfew functions as a specific prophylactic agent against migraine headaches through a multi-phased vascular and cellular control loop. The primary sesquiterpene lactone, parthenolide, binds to and inhibits $I\kappa B$ kinase, effectively blocking the NF-kB pathway to downregulate pro-inflammatory gene expression. Concurrently, it inhibits the release of serotonin ($5-HT$) and inflammatory granules from blood platelets and white blood cells, preventing the violent cranial vascular vasoconstriction and subsequent rebound vasodilation that characterizes the migraine cascade. It also suppresses inducible nitric oxide synthase (iNOS) and arachidonic acid synthesis to cool adjacent neuralgic tissue lines.

Clinical Applications & Indications

• Primary Indications: Prophylaxis (prevention) of migraine headaches (specifically vascular, throbbing migraines that are worsened by heat), and reduction of associated migraine symptoms (nausea, photophobia, phonophobia).
• Secondary Indications: Rheumatoid arthritis support, painful spasmodic dysmenorrhea, and tensive neuralgic face pain.
• Modern Clinical Evidence: Numerous randomized, double-blind, placebo-controlled human clinical trials confirm that regular daily administration of standardized Feverfew leaves significantly decreases the frequency, intensity, and duration of migraine attacks, establishing it as an effective long-term botanical prophylactic option.

Preparation, Dosing & Extraction Matrix

• Optimal Menstruum & Extraction Guidelines: Parthenolide is lipophilic and extracts optimally using a medium-to-high alcohol percentage (60–70% EtOH). CRITICAL CLINICAL LAW: Feverfew is a prophylactic preventer, not an acute abortive remedy. It must be taken daily consistently for a minimum of 4–8 weeks to structurally shift the vascular migraine threshold; taking it exclusively during an acute, active migraine attack yields minimal clinical benefit.

Standard Dosage Parameters

Safety Profile, Contraindications & Drug Interactions

• Contraindications: Absolutely contraindicated during pregnancy (exhibits strong emmenagogue and uterine-stimulating properties that risk abortifacient outcomes). Contraindicated in individuals with known severe hypersensitivity or contact dermatitis to other members of the Asteraceae family. Discontinue use 2 weeks prior to major surgical procedures.
• Side Effects & Toxicity Thresholds: Chewing fresh raw leaves can cause significant localized aphthous ulcerations (mouth sores), tongue swelling, and transient loss of taste due to the intense acridity of sesquiterpene lactones. Standardized capsules completely bypass this risk. Abrupt cessation after long-term use can cause a brief “post-feverfew syndrome” marked by rebound headaches, anxiety, and muscle stiffness.
• Pharmaceutical Cross-Interactions: * Enzyme Alterations: May mildly inhibit specific CYP2C19 liver pathway functions.
  • Additive Pathways: May enhance the actions of antiplatelet or anticoagulant pharmaceuticals (Warfarin, Aspirin) due to platelet aggregation inhibition; monitor clotting profiles closely.

References

1. Culpeper, N. (1653). The Complete Herbal.
2. Murphy, J. J., et al. (1988). Randomised double-blind placebo-controlled trial of feverfew in migraine prevention. Lancet, 2(8604), 189-192.
3. Vogler, B. K., et al. (1998). Feverfew as a preventive treatment for migraine: a systematic review. Cephalalgia, 18(10), 704-708.